Home › Sinus Histiocytosis
Sinus Histiocytosis clinical trials recruiting in the U.S.
6 studies for Sinus Histiocytosis are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Mirdametinib in Histiocytic Disorders
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Sep 21, 2026 · NCT06153173Histiocytic Disorder Follow-up Study
RecruitingObservational study
Ages 0 to 89 · All sexes · Updated Jun 12, 2026 · NCT05915208In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT05093335Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 8, 2026 · NCT03329274Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
RecruitingPhase 2
All ages · All sexes · Updated Sep 18, 2025 · NCT04079179International Rare Histiocytic Disorders Registry (IRHDR)
RecruitingObservational study
All ages · All sexes · Updated Jun 24, 2025 · NCT02285582From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.